Peter Pack

Peter brings over 27 years of international life sciences experience. He started his career at MorphoSys AG as co-inventor of one of the most commercially successful human antibody libraries. Following this, he was co-founder and CEO of MTM laboratories AG (Heidelberg, Germany and Westborough, US), which is now part of Roche Diagnostics. During his time as CEO, Peter successfully established a fully integrated diagnostic company from scratch, developing and internationally commercialising novel, biomarker-based CINtec® tests for the screening and diagnosis of cervical cancer. Between 2015 and 2019 he headed the Cambridge-based therapeutics company Crescendo Biologics, leading the transition from a transgenic platform company to a developer of multispecific biologics with an internal, late stage preclinical pipeline in oncology. Peter has served on a number of Boards and has headed up companies with up to 400 employees in the role of CEO and Managing Director.